NCT05007574

Brief Summary

Aging of the population is dramatically increasing the number of hospitalized patients, with the consequent challenges of limited medical personnel and resources in hospitals. Wireless technologies that create highly connected healthcare environments are developed to help hospitals address these issues, once these technologies are perfectly integrated in the hospital environment with respect to IT infrastructure for big data storage. Such devices have proven remarkable efficiencies in monitoring patients with high patient safety, data accuracy and security, which are essential to provide high quality patient care, reduce health-related costs and optimize the management of high numbers of patients. Cough is the most common condition that results in a visit to the physician. Often coughs are benign, but sometimes can be the sign of exacerbations of a chronic respiratory disease. Exacerbations are defined in the Global Initiative for Chronic Obstructive Lung Disease (GOLD) document "as an acute event characterised by a worsening of the patient's respiratory symptoms that is beyond normal day-to-day variations and leads to a change in medication". It is assumed that, if coughs were remotely monitored, hospitals might be unburdened, patients would be empowered to self-manage their health, and that prevention of serious respiratory diseases might be facilitated, thus improving health outcomes. Unfortunately, remote monitoring for cough that rely on self-reporting is impractical, as patients do not record data very reliably. On the contrary, a microphone on the bedside table connected to a medical data analysis platform might monitor patients' cough exacerbations at night and alert the medical staff immediately.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 7, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 16, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2022

Completed
Last Updated

August 16, 2021

Status Verified

July 1, 2021

Enrollment Period

2 months

First QC Date

July 7, 2021

Last Update Submit

August 13, 2021

Conditions

Keywords

coughexacerbationconnected device

Outcome Measures

Primary Outcomes (1)

  • Measurement of the clinical performance and accuracy of the microphone and of the analysis platform to detect coughs

    The microphone signal is recorded by a micro-computer and treated by the algorithm of the analysis platform developped by the company VNV. The aim of this algorithm is to discriminate events of cough in the signal. To measure the accuracy of the algorithm, we will compare the results obtained by the analysis plateform with a polygraph which is the classical way to measure night cough. The microphone of the polygraph placed on the patient chest will control if the events are due to patients coughs or patient movements. The 2 devices (microphone and polygraph) will be recording patients during 2 consecutive nights. Unit of measurement will be the number of cough events.

    2 nights

Secondary Outcomes (2)

  • Patients' acceptance on the connected microphone

    2 nights

  • Medical staff's satisfaction on both the microphone and the medical analysis platform (usability, data usage)

    5 days

Interventions

Remote data collection

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Male and female subjects aged ≥ 18 years fulfilling all of the inclusion criteria are eligible for the study. The presence of any one of the exclusion criteria will lead to exclusion of the participant.

You may qualify if:

  • Suffering from chronic obstructive pulmonary disease (COPD I to IV) or other respiratory diseases generating dry or productive cough and hospitalized for a minimal duration of 5 days
  • Living in the Canton of Neuchâtel
  • Understanding French

You may not qualify if:

  • Suffering from cognitive disorders
  • Refractory to test new technologies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ligue pulmonaire neuchâteloise

Peseux, Canton of Neuchâtel, 2034, Switzerland

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveRespiration DisordersCough

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms, RespiratorySigns and Symptoms

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 7, 2021

First Posted

August 16, 2021

Study Start

October 1, 2021

Primary Completion

December 1, 2021

Study Completion

February 1, 2022

Last Updated

August 16, 2021

Record last verified: 2021-07

Locations